FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Clinical trials for FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) explained in plain language.
Never miss a new study
Get alerted when new FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) trials appear
Sign up with your email to follow new studies for FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot aims to keep rare kidney diseases in check
Disease control Recruiting nowThis study tests an injection called BAT4406F in 192 adults with two rare kidney diseases (MCD or FSGS) that cause protein leakage and swelling. The goal is to see if the drug can reduce protein in urine and prevent relapses better than a placebo. Participants must have responded…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Phase: PHASE2, PHASE3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated May 26, 2026 10:40 UTC
-
Blood test could transform kidney disease diagnosis in kids
Diagnosis Recruiting nowThis study aims to improve how doctors diagnose a kidney condition called nephrotic syndrome in children. Researchers will use advanced blood tests and kidney tissue analysis to look for specific immune system markers (autoantibodies) that may cause the disease. By better underst…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Phase: NA • Sponsor: Meyer Children's Hospital IRCCS • Aim: Diagnosis
Last updated May 26, 2026 10:27 UTC